DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Reset all filters
01 1Dr. Reddy's Laboratories Limited
02 1Neuland Laboratories Limited
03 1AX Pharmaceutical Corp
04 1Alivus Life Sciences Limited
05 1Chromo Laboratories India Private Limited
06 1Formosa Laboratories, Inc.
07 1Jubilant Biosys limited
08 1Optimus Drugs Private Limited
09 1Pfizer Asia Manufacturing Pte Ltd
10 1Pharmacia and Upjohn Company LLC
11 1Professional Compounding Centers of America dba PCCA
12 2Symed Labs Limited
13 1Uquifa Spain
14 1Viatris Pharmaceuticals LLC
15 1ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.
16 1Zhejiang Changhai Pharmaceuticals Co., Ltd.
17 1Zydus Lifesciences Limited
Reset all filters
01 4LINEZOLID
02 13Linezolid
03 1linezolid (form-1)
Reset all filters
01 1Canada
02 2China
03 9India
04 1Spain
05 1Taiwan
06 3U.S.A
07 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-947
Start Marketing Date : 2013-03-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-2009
Start Marketing Date : 2017-12-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-019
Start Marketing Date : 2020-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 65372-1172
Start Marketing Date : 2013-03-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 59285-021
Start Marketing Date : 2020-12-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 51927-5293
Start Marketing Date : 2025-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 0009-5157
Start Marketing Date : 2014-07-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 49711-0121
Start Marketing Date : 2010-06-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 65427-821
Start Marketing Date : 2014-07-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 65841-166
Start Marketing Date : 2018-01-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

83
PharmaCompass offers a list of Linezolid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Linezolid manufacturer or Linezolid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linezolid manufacturer or Linezolid supplier.
A NDA 21-131 Zyvox for injection (linezolid injection) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NDA 21-131 Zyvox for injection (linezolid injection), including repackagers and relabelers. The FDA regulates NDA 21-131 Zyvox for injection (linezolid injection) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NDA 21-131 Zyvox for injection (linezolid injection) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NDA 21-131 Zyvox for injection (linezolid injection) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A NDA 21-131 Zyvox for injection (linezolid injection) supplier is an individual or a company that provides NDA 21-131 Zyvox for injection (linezolid injection) active pharmaceutical ingredient (API) or NDA 21-131 Zyvox for injection (linezolid injection) finished formulations upon request. The NDA 21-131 Zyvox for injection (linezolid injection) suppliers may include NDA 21-131 Zyvox for injection (linezolid injection) API manufacturers, exporters, distributors and traders.
click here to find a list of NDA 21-131 Zyvox for injection (linezolid injection) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NDA 21-131 Zyvox for injection (linezolid injection) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NDA 21-131 Zyvox for injection (linezolid injection) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NDA 21-131 Zyvox for injection (linezolid injection) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NDA 21-131 Zyvox for injection (linezolid injection) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NDA 21-131 Zyvox for injection (linezolid injection) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NDA 21-131 Zyvox for injection (linezolid injection) suppliers with NDC on PharmaCompass.
We have 16 companies offering NDA 21-131 Zyvox for injection (linezolid injection)
Get in contact with the supplier of your choice: